The Roche Investor Relations team would like to invite you to the Roche Diagnostics Day taking place in London on Tuesday, 27 May 2025, starting at 12:00 BST local time and finishing at 15:45 BST, followed by refreshments with the Roche Management Team. The Roche Diagnostics Day will address the following topics: Roche SBX Sequencing solution Roche Mass Spectrometry update Molecular Lab upcoming launches Pathology Lab upcoming launches Near Patient Care upcoming launches Core Lab upcoming launches Presenters include: Matt Sause, CEO Roche Diagnostics Palani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS) Moritz Hartmann, Global Head of Roche Information Solutions Josh Lauer, Head of Molecular Customer Labs Area Jill German, Head of Roche Pathology Customer Labs Area Ildiko Amann-Zalan, Head of Research & Development Roche Diagnostics Solutions Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems Olivier Gillieron, Lifecycle Leader Cardiometabolic and Neurology Meeting information: Date/Time (BST): Tuesday, 27 May 2025 12:00 - 13:00 Registration and lunch 13:00 - 15:45 Presentations & Q&A 15:45 - 16:15 Refreshments with Roche Management Team Venue Pan Pacific London 80 Houndsditch London EC3A 7AB > map To register for the event, please follow this > link (passcode: Dia2025). The slides will be available for download at 12:00 BST on the day of the event. > click here Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com . A replay of the event will be available via > roche.com/investors *privacy notice   Best regards,
Bruno Eschli Head of Investor Relations	Birgit Masjost Investor Relations Officer/Leader Diagnostics

 

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.